Discussions of drug pricing were few and far between in the initial days of the J.P. Morgan Healthcare Conference, but Pfizer Inc. CEO Albert Bourla was asked his thoughts on the topic during a presentation on 12 January. "We have arrived in a situation that we need to reform, that needs to change," he said. "I think it has become a unanimous … concern for all of us," Bourla said. "If you ask any of my peers and good friends, they will tell you that one of the highest concerns is that in the US patients are getting their medicines [as] if they don't have insurance, although they do have it."
J.P. Morgan Highlights: Pricing Reforms, Digital Tech And COVID
The annual J.P. Morgan Health Care Conference has come to a close. In Vivo has summarized some of the key themes to appear from 2021’s virtual meeting of industry leaders, investors and technology creators.
